143 related articles for article (PubMed ID: 25480734)
1. Pathway crosstalk analysis of microarray gene expression profile in human hepatocellular carcinoma.
Zhou X; Zheng R; Zhang H; He T
Pathol Oncol Res; 2015 Jul; 21(3):563-9. PubMed ID: 25480734
[TBL] [Abstract][Full Text] [Related]
2. Identification of dysfunctional biological pathways and their synergistic mechanism in hepatocellular carcinoma process.
Liang J; Lv J; Liu Z
Exp Mol Pathol; 2015 Jun; 98(3):540-5. PubMed ID: 25805103
[TBL] [Abstract][Full Text] [Related]
3. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
[TBL] [Abstract][Full Text] [Related]
4. Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.
Liu F; Li H; Chang H; Wang J; Lu J
Tumori; 2015; 101(2):206-14. PubMed ID: 25768320
[TBL] [Abstract][Full Text] [Related]
5. Identifying significant pathways of hepatitis B virus-related hepatocellular carcinoma based on crosstalk and network pathways.
Wen LM; Wu WZ; Peng XC
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27420970
[TBL] [Abstract][Full Text] [Related]
6. Inferring pathway crosstalk networks using gene set co-expression signatures.
Wang T; Gu J; Yuan J; Tao R; Li Y; Li S
Mol Biosyst; 2013 Jul; 9(7):1822-8. PubMed ID: 23591523
[TBL] [Abstract][Full Text] [Related]
7. Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network.
Chen W; Jiang J; Wang PP; Gong L; Chen J; Du W; Bi K; Diao H
DNA Cell Biol; 2019 Oct; 38(10):1112-1124. PubMed ID: 31464520
[TBL] [Abstract][Full Text] [Related]
8. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
9. Classifier of cross talk genes predicts the prognosis of hepatocellular carcinoma.
Zhai X; Xue Q; Liu Q; Guo Y; Chen Z
Mol Med Rep; 2017 Sep; 16(3):3253-3261. PubMed ID: 28713927
[TBL] [Abstract][Full Text] [Related]
10. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
[TBL] [Abstract][Full Text] [Related]
11. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
[TBL] [Abstract][Full Text] [Related]
12. Pathway crosstalk analysis of non-small cell lung cancer based on microarray gene expression profiling.
Xing C; Zhang R; Cui J; Li Y; Li G; Yang Y; Pang L; Ruan X; Li J
Tumori; 2015; 101(1):111-6. PubMed ID: 25702679
[TBL] [Abstract][Full Text] [Related]
13. Gene network analysis reveals a novel 22-gene signature of carbon metabolism in hepatocellular carcinoma.
Zhang J; Baddoo M; Han C; Strong MJ; Cvitanovic J; Moroz K; Dash S; Flemington EK; Wu T
Oncotarget; 2016 Aug; 7(31):49232-49245. PubMed ID: 27363021
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
15. CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.
Qu Z; Li D; Xu H; Zhang R; Li B; Sun C; Dong W; Zhang Y
Ann Hepatol; 2016; 15(4):568-76. PubMed ID: 27236156
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells.
Ding M; Li J; Yu Y; Liu H; Yan Z; Wang J; Qian Q
J Transl Med; 2015 Aug; 13():259. PubMed ID: 26259570
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of gene expression profiles indicates genes in spliceosome pathway are up-regulated in hepatocellular carcinoma (HCC).
Xu W; Huang H; Yu L; Cao L
Med Oncol; 2015 Apr; 32(4):96. PubMed ID: 25731616
[TBL] [Abstract][Full Text] [Related]
18. Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array.
Liu Y; Wang P; Li S; Yin L; Shen H; Liu R
Int J Clin Exp Pathol; 2015; 8(3):3027-35. PubMed ID: 26045814
[TBL] [Abstract][Full Text] [Related]
19. [Not Available].
Fa B; Luo C; Tang Z; Yan Y; Zhang Y; Yu Z
EBioMedicine; 2019 Jun; 44():250-260. PubMed ID: 31101593
[TBL] [Abstract][Full Text] [Related]
20. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
